Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?' by Braun and Landewe

Ann Rheum Dis. 2021 Nov 29:annrheumdis-2021-221799. doi: 10.1136/annrheumdis-2021-221799. Online ahead of print.NO ABSTRACTPMID:34844925 | DOI:10.1136/annrheumdis-2021-221799

Source: Pain Physician - November 30, 2021 Category: Anesthesiology Authors: Stefan Siebert Helena Marzo-Ortega Source Type: research